Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

CVS Stock Forecast, Analyst Ratings, Earnings and Price Target

NYSE : CVS

CVS Health Corporation

$63.85
0.19+0.30%
At Close 4:00 PM
$68.00
4.15+6.50%
After-Market 08:30 PM
64.14
BESG ScoreESG Rating

CVS eps in a glimpse

Growth Next 5yrs
13.56%
Last Quarter
$1.09
Past Year
$3.66
Growth Past 5yrs
-6.37%
Next Quarter
$1.65
Estimate Next Year
-$0.80

Analyst Rating Consensus

Created with Highcharts 10.3.3

7

Ratings

6Strong Buy
1Buy
0Hold
0Sell
0Strong Sell
Strong Buy

CVS Price Target

Highest Price Target

$81.00

(

27.24% Upside

)

Mean Price Target

$73.86

(

16.02% Upside

)

Lowest Price Target

$65.00

(

2.1% Upside

)

CVS Recent Analyst Ratings

DatePrice TargetRating StatusRatingAnalystFirm
Mar 21, 202572.0 → 74.0MaintainsOverweightJessica TassanPiper Sandler
Feb 18, 202580.0 → 81.0MaintainsOverweightLisa GillJP Morgan
Feb 13, 202571.0 → 73.0MaintainsOverweightAndrew MokBarclays
Feb 13, 202555.0 → 75.0UpgradeMarket Perform → OutperformMichael ChernyLeerink Partners
Feb 13, 202568.0 → 73.0MaintainsOverweightStephen BaxterWells Fargo
Feb 13, 202560.0 → 76.0MaintainsBuyDavid MacdonaldTruist Securities
Jan 27, 202560.0 → 65.0MaintainsOutperformElizabeth AndersonEvercore ISI Group
Jan 06, 202567.0 → 60.0MaintainsBuyDavid MacdonaldTruist Securities
Dec 03, 202466.0UpgradeHold → BuyGeorge HillDeutsche Bank
Nov 25, 202472.0 → 64.0MaintainsOverweightJessica TassanPiper Sandler
Nov 25, 202473.0 → 80.0MaintainsBuyCharles RyheeTD Cowen
Nov 20, 202476.0 → 67.0ReiteratesBuyDavid MacdonaldTruist Securities
Nov 18, 202460.0 → 66.0UpgradeEqual-Weight → OverweightStephen BaxterWells Fargo
Nov 15, 202468.0 → 58.0MaintainsOutperformBen HendrixRBC Capital
Oct 11, 202466.0 → 76.0MaintainsBuyDavid MacdonaldTruist Securities
Oct 10, 202463.0 → 82.0UpgradeEqual-Weight → OverweightAndrew MokBarclays
Oct 08, 202462.0 → 75.0MaintainsOutperformElizabeth AndersonEvercore ISI Group
Oct 04, 202459.0 → 85.0UpgradeHold → BuyCharles RyheeTD Cowen
Oct 01, 202462.0ReiteratesNeutralSarah JamesCantor Fitzgerald
Sep 16, 202462.0ReiteratesNeutralSarah JamesCantor Fitzgerald
Aug 19, 202462.0ReiteratesNeutralSarah JamesCantor Fitzgerald
Jul 23, 202458.0ReiteratesNeutralSarah JamesCantor Fitzgerald
May 08, 2024100.0 → 80.0MaintainsBuyChris GrajaArgus Research
May 07, 202476.0 → 60.0MaintainsEqual-WeightStephen BaxterWells Fargo
May 07, 202499.0 → 59.0DowngradeBuy → HoldCharles RyheeTD Cowen
May 07, 202499.0 → 59.0DowngradeBuy → HoldTD Cowen
May 02, 202490.0 → 66.0ReiteratesBuyDavid MacdonaldTruist Securities
May 02, 202495.0 → 77.0MaintainsBuyMichael ChernyB of A Securities
May 02, 202485.0 → 74.0MaintainsBuyNathan RiceGoldman Sachs
May 02, 202478.0 → 63.0MaintainsEqual-WeightAndrew MokBarclays
May 02, 202485.0 → 60.0DowngradeBuy → NeutralKevin CaliendoUBS
May 02, 202486.0 → 72.0MaintainsBuyAnn HynesMizuho
May 02, 202485.0 → 60.0DowngradeBuy → NeutralUBS
May 01, 202460.0DowngradeOutperform → Market PerformMichael ChernyLeerink Partners
May 01, 202487.0 → 58.0DowngradeOverweight → NeutralSarah JamesCantor Fitzgerald
May 01, 2024NoneDowngradeOverweight → NeutralCantor Fitzgerald
Mar 06, 202478.0InitiatedEqual WeightBarclays
Feb 26, 202488.0InitiatedOutperformLeerink Partners

Actual EPS vs Estimated EPS

Created with Highcharts 10.3.3Actual EPSEstimated EPSTrend2023-08-022023-11-012024-02-072024-05-012024-08-072024-11-0600.20.40.60.811.21.41.61.822.22.4

How EPS can be helpful

Understanding the true essence of Earnings Per Share (EPS) for a company can be a complex endeavor. EPS, essentially a measure of a company's profitability on a per-share basis, is often used by investors as a barometer of financial health. However, it's crucial to recognize that EPS can be subject to manipulation through various accounting techniques and management strategies.

CVS Earnings History

Report DateActualForecastSurprise Factor
Nov 06, 20241.091.44-24.31%
Aug 07, 20241.831.73+5.78%
May 01, 20242.121.69+25.44%
Feb 07, 20241.582-21.00%
Nov 01, 20232.212.13+3.76%
Aug 02, 20232.212.12+4.25%

After EPS - Where did the stock go?

Earning DateClosing Price Before EarningBefore Closing Price ChangeNext Day Closing PriceNext Day Price ChangeOn 7th Day Closing PriceOn 7th Day Closing Change
Nov 06, 2024$55.34-10.18%$57.07-7.37%$54.27-11.91%
Aug 07, 2024$58.34+3.31%$57.85+2.44%$55.99-0.85%
May 01, 2024$67.71+20.25%$55.15-2.06%$54.91-2.49%
Feb 07, 2024$73.76-3.01%$75.08-1.28%$76.41+0.47%
Nov 01, 2023$69.01+0.41%$69.64+1.32%$68.75+0.03%
Aug 02, 2023$73.95-3.22%$74.32-2.74%$74.60-2.37%

Frequently Asked Questions

Is CVS stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given CVS stock an average recommendation of Strong Buy. 7 analysts have given their ratings to CVS out of which 6 analysts have given strong buy call, 1 analysts have given buy call, 0 analysts rate it hold, 0 analysts advocate strong sell call, and 0 analysts has given sell rating. The average target price of $73.86 gives the stock implied upside of roughly 16.02% over the next year or so.
What have analysts suggested for CVS highest price target?
Analysts suggest CVS's stock price would rise to a high of $81.00.
What is the lowest price target analysts expect for CVS over the next year?
Within the next 12 months, analysts predict the CVS stock price could move to $65.00.
What is the average target price for CVS?
CVS stock has an average analyst estimate of $73.86.
At its current price, how far is CVS from its average target price?
CVS shares are currently trading 16.02% above this price target.
What were CVS’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at $1.09 versus consensus estimates of $1.44, and below the comparable year-ago quarter’s EPS of $2.21.
What are the current estimates for quarterly and annual earnings per share?
CVS's forecasts by analysts estimating quarterly EPS at $1.65 and -$0.80 for the whole year.
What has CVS's growth been in the past five years and what is expected in the next five years?
The analysts have projected 13.56% EPS growth for CVS in the next five years, compared to growth rates of -6.37% in the past five years.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph